Company / Operating Income per Share
Lipocine Inc. Operating Income per Share History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.22
FY2025
5-year range
-$3.37 / $0.04
FY2021-FY2025
Trend
+93.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share returned to growth in FY2025 after 2 years of decline, reaching $-0.22.
Based on SEC 10-K filings.
-0.22 in FY2025.
Improved from $-2.32 to $-0.22 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 93.6% year-over-year.
- Peak operating income per share was recorded in FY2013.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.16 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.22 | +93.6% |
| FY2024 | -$3.37 | -45.7% |
| FY2023 | -$2.32 | -6598.3% |
| FY2022 | $0.04 | +113.9% |
| FY2021 | -$0.26 | +25.0% |
| FY2020 | -$0.34 | +34.3% |
| FY2019 | -$0.52 | +42.2% |
| FY2018 | -$0.90 | -203.7% |
| FY2013 | $0.87 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026